Venture Capital Access Online | The eMarketplace for the Venture Capital Industry

 

Bookmark and Share   

Home

Marketplace
Database
News
Store
Resources
Contact Us

 

 

 

News

 

Venture Capital Database 2017 Now Available!

SV Life Sciences Changes Name to SV Health Investors to Better Reflect the Firm's Longstanding Strategy and Focus

BOSTON, Mass., April 10, 2017-- SV Life Sciences has changed its name to SV Health Investors, the healthcare and life sciences venture capital and growth equity firm announced today.

The new name is geared to better reflect the firm's longstanding strategy and multi-sector focus. The firm targets early-stage opportunities in biotechnology; early-stage and revenue-stage opportunities in medical devices; and growth equity investments for later-stage businesses in healthcare services and digital health.

SV team members have deep healthcare domain expertise, extensive operating experience and broad networks. They apply these qualities to their work with portfolio companies as hands-on advisers and partners, from formation or recapitalization to exit.

SV Health Investors' funds have approximately $2.0 billion of capital commitments under management. Over the past 20 years, SV has invested in over 175 companies. The firm is headquartered in Boston and has offices in London and San Francisco.

For more information, please contact Katarina Wenk-Bodenmiller of Sommerfield Communications at (212) 255-8386 or Katarina@sommerfield.com.

Contact:
Katarina Wenk-Bodenmiller
Sommerfield Communications
(212) 255-8386
Katarina@sommerfield.com


News Index

Venture Capital Database 

 

 NEWS

Latest VC News
VC News Archive
News Search
RSS News Feed

List Your Firm

Entrepreneurs
Investors
Advisors

Venture Capital Database

VCPro Database
Download Trial
Buy Now

VC Tools

VC Pitch
Private Placement Memorandum

Business Plan Tools

Free Business Plan Template
Business Plan Tools

 

 

Copyright © 1998-2017 Access InterComm  All rights reserved. 
Site Map | Privacy Statement | Legal Notice & Disclaimer